PMID- 26408408 OWN - NLM STAT- MEDLINE DCOM- 20160808 LR - 20181113 IS - 2210-7711 (Electronic) VI - 37 IP - 6 DP - 2015 Dec TI - Validation of the Physician-Pharmacist Collaborative Index for physicians in Malaysia. PG - 1242-9 LID - 10.1007/s11096-015-0200-6 [doi] AB - BACKGROUND: Establishing a collaborative working relationship between doctors and pharmacists is essential for the effective provision of pharmaceutical care. The Physician-Pharmacist Collaborative Index (PPCI) was developed to assess the professional exchanges between doctors and pharmacists. Two versions of the PPCI was developed: one for physicians and one for pharmacists. However, these instruments have not been validated in Malaysia. OBJECTIVE: To determine the validity and reliability of the PPCI for physicians in Malaysia. SETTING: An urban tertiary hospital in Malaysia. METHODS: This prospective study was conducted from June to August 2014. Doctors were grouped as either a "collaborator" or a "non-collaborator". Collaborators were doctors who regularly worked with one particular clinical pharmacist in their ward, while non-collaborators were doctors who interacted with any random pharmacist who answered the general pharmacy telephone line whenever they required assistance on medication-related enquiries, as they did not have a clinical pharmacist in their ward. Collaborators were firstly identified by the clinical pharmacist he/she worked with, then invited to participate in this study through email, as it was difficult to locate and approach them personally. Non-collaborators were sampled conveniently by approaching them in person as these doctors could be easily sampled from any wards without a clinical pharmacist. The PPCI for physicians was administered at baseline and 2 weeks later. MAIN OUTCOME MEASURE: Validity (face validity, factor analysis and discriminative validity) and reliability (internal consistency and test-retest) of the PPCI for physicians. RESULTS: A total of 116 doctors (18 collaborators and 98 non-collaborators) were recruited. Confirmatory factor analysis confirmed that the PPCI for physicians was a 3-factor model. The correlation of the mean domain scores ranged from 0.711 to 0.787. "Collaborators" had significantly higher scores compared to "non-collaborators" (81.4 +/- 10.1 vs. 69.3 +/- 12.1, p < 0.001). The Cronbach alpha for the overall PPCI for physicians was 0.949, while the Cronbach alpha values for the individual domains ranged from 0.877 to 0.926. Kappa values at test-retest ranged from 0.553 to 0.752. CONCLUSION: The PPCI for physicians was a valid and reliable measure in determining doctors' views about collaborative working relationship with pharmacists, in Malaysia. FAU - Sellappans, Renukha AU - Sellappans R AD - Department of Primary Care Medicine, University Malaya Primary Care Research Group (UMPCRG), Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. FAU - Ng, Chirk Jenn AU - Ng CJ AD - Department of Primary Care Medicine, University Malaya Primary Care Research Group (UMPCRG), Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. FAU - Lai, Pauline Siew Mei AU - Lai PS AD - Department of Primary Care Medicine, University Malaya Primary Care Research Group (UMPCRG), Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. plai@ummc.edu.my. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150925 PL - Netherlands TA - Int J Clin Pharm JT - International journal of clinical pharmacy JID - 101554912 SB - IM MH - Adult MH - Attitude of Health Personnel MH - Communication MH - *Cooperative Behavior MH - Female MH - Humans MH - *Interprofessional Relations MH - Malaysia MH - Male MH - Middle Aged MH - Personnel, Hospital MH - *Pharmacists MH - *Physicians MH - Prospective Studies MH - Reproducibility of Results MH - Surveys and Questionnaires/*standards MH - Tertiary Care Centers OTO - NOTNLM OT - Collaboration OT - Hospitals OT - Interprofessional relations OT - Malaysia OT - Pharmacists OT - Physicians EDAT- 2015/09/27 06:00 MHDA- 2016/08/09 06:00 CRDT- 2015/09/27 06:00 PHST- 2015/02/07 00:00 [received] PHST- 2015/09/21 00:00 [accepted] PHST- 2015/09/27 06:00 [entrez] PHST- 2015/09/27 06:00 [pubmed] PHST- 2016/08/09 06:00 [medline] AID - 10.1007/s11096-015-0200-6 [pii] AID - 10.1007/s11096-015-0200-6 [doi] PST - ppublish SO - Int J Clin Pharm. 2015 Dec;37(6):1242-9. doi: 10.1007/s11096-015-0200-6. Epub 2015 Sep 25.